Combination Therapy In Dyslipidemia için kapak resmi
Başlık:
Combination Therapy In Dyslipidemia
Yazar:
Banach, Maciej. editor.
ISBN:
9783319204338
Basım Bilgisi:
1st ed. 2015.
Fiziksel Tanımlama:
VIII, 205 p. 22 illus., 15 illus. in color. online resource.
İçerik:
Foreword -- Statins and bile acid resins - is there a place for such a combination? -- Statins and fibrates - should it be recommended? -- Statins and ezetimibe - doubts or bright future? -- Statins and niacin - the end of residual risk therapy? -- Statins and omega-3 fatty acids - what more do we need? -- Statins and CETP inhibitors - anacetrapib and evacetrapib - the last hope? -- Statins and mipomersen - the issue of tolerability? -- Statins and lomitapide - a suitable response for HoFH -- Statins and PCSK9 inhibitors - defining the correct patients -- Other possible drug combination for dyslipidaemia -- Statins and nutraceuticals/functional food - Could be they combined? -- Lipid lowering therapy and apheresis - indications and outcomes -- Combination of lipid lowering agents with antihypertensive drugs - a joint fight against the two most important risk factors? -- Not only dyslipidaemia therapy - the time for polypills -- Drug Evaluation: Fenofibrate + simvastatin for the treatment of dyslipidemia: When and for whom? -- Drug Evaluation: Olmesartan medoxomil + rosuvastatin for the treatment of dyslipidemia and concomitant risk factors: A chance for better compliance? -- Conclusions and Take Home Message.
Yazar Ek Girişi:
Tüzel Kişi Ek Girişi:
Ayırtma:
Kopya:

Rafta:*

Kütüphane
Materyal Türü
Demirbaş Numarası
Yer Numarası
Durumu/İade Tarihi
Materyal Ayırtma
Arıyor...
E-Kitap 519674-1001 XX(519674.1)
Arıyor...

On Order